R.M. Davis Inc’s AstraZeneca AZN Stock Holding History

R.M. Davis Inc’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$355K	Buy	1,871 +150	+9%	+$28.2K	0.01%	235
2026 Q1	$339K	Sell	1,721 -239	-12%	-$46.1K	0.01%	229
2025 Q4	$360K	Buy	1,960 +189	+11%	+$33.1K	0.01%	217
2025 Q3	$272K	Hold	1,771	–	–	﹤0.01%	246
2025 Q2	$248K	Sell	1,771 -179	-9%	-$25.1K	﹤0.01%	245
2025 Q1	$287K	Sell	1,950 -97	-5%	-$14K	0.01%	241
2024 Q4	$268K	Buy	+2,047	New	+$287K	0.01%	238

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

R.M. Davis Inc's AZN Position: Q2 2026 in Review

R.M. Davis Inc increased its AstraZeneca (AZN) stake by 8.7% in Q2 2026, buying an estimated $28.2K and bringing the position to 1,871 shares worth $355K. The position accounts for 0.01% of the portfolio, ranked #235.

R.M. Davis Inc first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $360K in Q4 2025. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

R.M. Davis Inc held 1,871 shares of AstraZeneca worth $355K as of Q2 2026.
R.M. Davis Inc bought 150 AstraZeneca shares in Q2 2026, an estimated $28.2K.
AstraZeneca made up 0.01% of R.M. Davis Inc's portfolio in Q2 2026, its #235 holding.
R.M. Davis Inc first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
R.M. Davis Inc's AstraZeneca position peaked at $360K in Q4 2025.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on R.M. Davis Inc's 13F filing for Q2 2026, filed 14 Aug 2026.